You are here: Industry Insights > prescription

News List

Bayer Group Restructures contractpharma
December 03, 2018
The Bayer Group is restructuring its core life science businesses through a series of portfolio, efficiency and structural measures that will result in the reduction of approximately 12,000 jobs worldwide...
NHS moves to clamp down on incorrect/fraudulent prescriptions pharmatimes
November 27, 2018
A new NHS campaign is striving to clamp down on the millions of pounds worth of prescriptions incorrectly claimed for free each year.
Medical cannabis made available on prescription in the UK europeanpharmaceuticalreview
November 02, 2018
Medical cannabis is now avaliable through the NHS, but many are warning about its drawbacks and that it won’t be available for those who need it…
RxHealth raises $1.8M seed round, launches Bulk Prescription October 25, 2018
Rx.Health curates digital solutions that are clinically proven to improve patient health, lowering the cost for health systems as they transition to value-based care.
FDA conducts major global operation to protect consumers from potentially dangerous prescription dru worldpharmanews
September 27, 2017
The U.S. Food and Drug Administration, in partnership with international regulatory and law enforcement agencies, recently took action against more than 500 websites that illegally sell potentially dangerous, unapproved versions of prescription medicines
Shooting for the moon: The National Cancer Institute’s Formulary pharmafile
July 31, 2017
Pharmafile spoke to National Cancer Institute's (NCI) Jason Christofaro and Sherry Ansher regarding the development of an agent formulary and its role as part of the wider Moonshot Initiative.
Fresenius Kabi Acquires Akorn in $4.3bn Deal contractpharma
April 27, 2017
Strategically complementary combination to enhance and diversify Fresenius Kabi’s business and portfolio
NHS England plans cull of ‘low-value’ prescriptions pharmatimes
March 29, 2017
“Low-value” prescriptions such as sun cream and gluten-free foods may soon no longer be available on the National Health Service in England, after NHS England announced a review into whether they should continue to be funded by the health service.

Previous page 1 2 3 4 Next page